The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

In this exclusive interview with the WSWS, Dr. Daszak recounts the story of his persecution and that of other principled ...

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

U.S. senators questioned the head of the FDA today about who will be eligible for a COVID-19 booster in the fall. The agency ...